The MHRA has approved trofolastat to identify how far high-risk prostate cancer has spread before treatment, to detect ...

Cells throughout the body work together like singers in a choir to keep us healthy, as long as they work in perfect harmony.

The Medicines and Healthcare products Regulatory Agency (MHRA) in the UK said it has given a world-first approval to Rotop's ...

The MHRA has approved the product for three clinical settings, including identifying how far high-risk prostate cancer has ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved trofolastat (RoTecPSMA), the first prostate-specific membrane antigen (PSMA)-targeting product authorised for use with ...

Diagnostic imaging plays an important role in identifying cancerous areas, which may help guide treatment decisions.

Trofolastat is a prostate-specific membrane antigen-targeting agent cleared for use with Technetium-99m for cancerous lesion ...

A lost sheep has been shepherded to safety following a group effort by emergency services in Mount Cottrell last night. The ewe found itself feeling rather sheepish after falling about 2 metres down ...

A British start-up has been revealed to have secured a £1 million prize from the UK government for a breakthrough AI technology that is transforming how new materials are developed.